2-165294010-T-TAA
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BA1
The ENST00000283256(SCN2A):c.-150_-149dupAA variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.31 ( 3463 hom., cov: 0)
Exomes 𝑓: 0.058 ( 51 hom. )
Consequence
SCN2A
ENST00000283256 5_prime_UTR
ENST00000283256 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.292
Genes affected
SCN2A (HGNC:10588): (sodium voltage-gated channel alpha subunit 2) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.369 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN2A | NM_001040142.2 | c.-51-1736_-51-1735dupAA | intron_variant | ENST00000375437.7 | NP_001035232.1 | |||
SCN2A | NM_001371246.1 | c.-51-1736_-51-1735dupAA | intron_variant | ENST00000631182.3 | NP_001358175.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000283256 | c.-150_-149dupAA | 5_prime_UTR_variant | 1/27 | 1 | ENSP00000283256.6 | ||||
SCN2A | ENST00000375437.7 | c.-51-1736_-51-1735dupAA | intron_variant | 5 | NM_001040142.2 | ENSP00000364586.2 | ||||
SCN2A | ENST00000631182.3 | c.-51-1736_-51-1735dupAA | intron_variant | 5 | NM_001371246.1 | ENSP00000486885.1 | ||||
SCN2A | ENST00000424833.5 | c.-51-1736_-51-1735dupAA | intron_variant | 1 | ENSP00000406454.2 | |||||
SCN2A | ENST00000283256.10 | c.-177_-176insAA | upstream_gene_variant | 1 | ENSP00000283256.6 |
Frequencies
GnomAD3 genomes AF: 0.313 AC: 17586AN: 56108Hom.: 3463 Cov.: 0
GnomAD3 genomes
AF:
AC:
17586
AN:
56108
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0580 AC: 5485AN: 94626Hom.: 51 Cov.: 0 AF XY: 0.0597 AC XY: 2710AN XY: 45412
GnomAD4 exome
AF:
AC:
5485
AN:
94626
Hom.:
Cov.:
0
AF XY:
AC XY:
2710
AN XY:
45412
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.313 AC: 17586AN: 56118Hom.: 3463 Cov.: 0 AF XY: 0.300 AC XY: 7337AN XY: 24424
GnomAD4 genome
AF:
AC:
17586
AN:
56118
Hom.:
Cov.:
0
AF XY:
AC XY:
7337
AN XY:
24424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Early Infantile Epileptic Encephalopathy, Autosomal Dominant Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Seizures, benign familial infantile, 3 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 21, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at